SlideShare uma empresa Scribd logo
1 de 13
DOPAMINE
HYPOTHESIS
LEARNING OBJECTIVES

You must:
• Describe the role of Dopamine (DA)
  in schizophrenia
You should:
• Outline evidence to support the
  hypothesis
You could:
• Evaluate the Dopamine Hypothesis
Lets remind ourselves how
 neurotransmitters work
Lets remind ourselves how
 neurotransmitters work
DOPAMINE
                  HYPOTHESIS
The Dopamine hypothesis states that the
  brain of schizophrenic patients produces
  more dopamine than normal brains.

  –Evidence comes from
     –studies with drugs
     –post mortems
     –pet scans
Elevated Level of
        Normal Level of
                                          Dopamine In The Brain of a
        Dopamine In The
                                            Schizophrenic Patient
         Human Brain
                                          (specifically the D2 receptor)




 Neurons that use the transmitter ‘dopamine’ fire too often and transmit
  too many messages or too often.
 Certain D2 receptors are known to play a key role in guiding attention.
 Lowering DA activity helps remove the symptoms of schizophrenia
ROLE OF DRUGS

–Amphetamines (agonists) lead to increase in DA
levels
–Large quantities lead to delusions and
hallucinations
–If drugs are given to schizophrenic patients their
symptoms get worse
Parkinson’s disease
              • Parkinson’s sufferers have low
                levels of dopamine
              • L-dopa raises DA activity
              • People with Parkinson's develop
                schizophrenic symptoms if they
                take too much L-dopa



–Chlorphromazine (given to schizophrenics) reduces
the symptoms by blocking D2 receptors
POST MORTEM


Falkai et al 1988
 Autopsies have found that people with
  schizophrenia have a larger than usual number
  of dopamine receptors.
 Increase of DA in brain structures and receptor
  density (left amygdala and caudate nucleus
  putamen)
• Concluded that DA production is abnormal for
  schizophrenia
PET SCANS


Lindstroem et al (1999)
• Radioactively labelled a chemical L-Dopa
• administered to 10 patients with
  schizophrenia and 10 with no diagnosis
• L-Dopa taken up quicker with
  schizophrenic patients
• Suggests they were producing more DA
  than the control group
hatch from
 eggs, but a   Which Came First?
    mother
   chicken         The Chicken or the Egg?
 must keep
an egg warm
in order for
 it to hatch
    Schizophrenia or Faulty
           Chemicals?
    Faulty chemicals cause
schizophrenia but schizophrenia
  may cause faulty chemicals


 Drugs may influence other systems that impact on
 schizophrenia so cant be 100% sure about their
 effects
ACTIVITY
• Use the evaluation points to write effective
  AO2 commentary for the studies on the
  handout
• You must comment on how the evidence you use supports or
challenges the DA hypothesis.
• You should comment on evidence both for and against the
hypothesis.
• You could use your own skills and knowledge to make
additional critical and evaluative points.
EVALUATION POINTS
•   There is a lack of correspondence between taking the drugs and
    signs of clinical effectiveness. It takes 4 weeks to see any sign that
    the drugs are working when they begin to block dopamine
    immediately. We can not seem to explain this time difference.
•   It could be that the development of receptors in one part of the brain
    may inhibit the development in another.
•   Type 1 cases respond well to conventional anti-psychotic drugs.
    Drugs such as CHLOPROMAZINE: Only effective at relieving the
    Positive Symptoms of the Illness.
•   Not good at explaining negative symptoms. Therefore suggested that
    Type 2 is related to a different kind of abnormality such as brain
    structure.
•   PET scans have suggested that drugs did not reduce symptoms of
    patients diagnosed with disorder for 10 yrs or more
•   There may be other neurotransmitters involved.
•   Possible that social and environmental factors trigger the condition.

Mais conteúdo relacionado

Mais procurados

Neuropsychiatric aspects of Thyroid
Neuropsychiatric aspects of ThyroidNeuropsychiatric aspects of Thyroid
Neuropsychiatric aspects of Thyroid
Cijo Alex
 

Mais procurados (20)

Dopamine, dopaminergic system, parkinson's disease, pharmacotherapy and modul...
Dopamine, dopaminergic system, parkinson's disease, pharmacotherapy and modul...Dopamine, dopaminergic system, parkinson's disease, pharmacotherapy and modul...
Dopamine, dopaminergic system, parkinson's disease, pharmacotherapy and modul...
 
Dopamine
DopamineDopamine
Dopamine
 
Long acting antipsychotics
Long acting antipsychoticsLong acting antipsychotics
Long acting antipsychotics
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
 
Treatment of schizophrenia
Treatment of schizophreniaTreatment of schizophrenia
Treatment of schizophrenia
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Neuropsychiatric aspects of Thyroid
Neuropsychiatric aspects of ThyroidNeuropsychiatric aspects of Thyroid
Neuropsychiatric aspects of Thyroid
 
Antidepressants - Pharmacology
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - Pharmacology
 
obsessive compulsive disorder
obsessive compulsive disorderobsessive compulsive disorder
obsessive compulsive disorder
 
Dopamine Receptors by Manisha
Dopamine Receptors by ManishaDopamine Receptors by Manisha
Dopamine Receptors by Manisha
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugs
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Antipsychotics agents
Antipsychotics agents Antipsychotics agents
Antipsychotics agents
 
Anxiety Disorders
Anxiety DisordersAnxiety Disorders
Anxiety Disorders
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Typical antipsychotic
Typical antipsychoticTypical antipsychotic
Typical antipsychotic
 
Side effects of Antipsychotic Agents
Side effects of Antipsychotic AgentsSide effects of Antipsychotic Agents
Side effects of Antipsychotic Agents
 

Semelhante a Dopamine hypothesis

Drugsandthe Brain Part4 Neuroleptics
Drugsandthe Brain Part4 NeurolepticsDrugsandthe Brain Part4 Neuroleptics
Drugsandthe Brain Part4 Neuroleptics
vacagodx
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
raj kumar
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
raj kumar
 
pharmacology of Antipsychotic Agents & Lithium.ppt
pharmacology of Antipsychotic Agents & Lithium.pptpharmacology of Antipsychotic Agents & Lithium.ppt
pharmacology of Antipsychotic Agents & Lithium.ppt
NorhanKhaled15
 
Neurobiology of schizophrenia
Neurobiology of schizophreniaNeurobiology of schizophrenia
Neurobiology of schizophrenia
Hareesh R
 

Semelhante a Dopamine hypothesis (20)

Drugsandthe Brain Part4 Neuroleptics
Drugsandthe Brain Part4 NeurolepticsDrugsandthe Brain Part4 Neuroleptics
Drugsandthe Brain Part4 Neuroleptics
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
antipsycotic drug.pptx
antipsycotic drug.pptxantipsycotic drug.pptx
antipsycotic drug.pptx
 
Monoamines in psychiatric disorders
Monoamines in psychiatric disordersMonoamines in psychiatric disorders
Monoamines in psychiatric disorders
 
pharmacology of Antipsychotic Agents & Lithium.ppt
pharmacology of Antipsychotic Agents & Lithium.pptpharmacology of Antipsychotic Agents & Lithium.ppt
pharmacology of Antipsychotic Agents & Lithium.ppt
 
Case study of schizophrenia
Case study of schizophreniaCase study of schizophrenia
Case study of schizophrenia
 
Antipsychotic agents
Antipsychotic agentsAntipsychotic agents
Antipsychotic agents
 
antipsychoticagents-160719173022.pdf
antipsychoticagents-160719173022.pdfantipsychoticagents-160719173022.pdf
antipsychoticagents-160719173022.pdf
 
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparationsAntipsychotic : Dr Rahul Kunkulol's Power point preparations
Antipsychotic : Dr Rahul Kunkulol's Power point preparations
 
Typical antipsychotics
Typical antipsychoticsTypical antipsychotics
Typical antipsychotics
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Neurobiology of schizophrenia
Neurobiology of schizophreniaNeurobiology of schizophrenia
Neurobiology of schizophrenia
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Shizophrenia
ShizophreniaShizophrenia
Shizophrenia
 
Shizophrenia
ShizophreniaShizophrenia
Shizophrenia
 
Chapter 15: Psychological Disorders
Chapter 15: Psychological DisordersChapter 15: Psychological Disorders
Chapter 15: Psychological Disorders
 
Neurotransmitter - Dopamine
Neurotransmitter - DopamineNeurotransmitter - Dopamine
Neurotransmitter - Dopamine
 
Antipsychotic Agents
Antipsychotic AgentsAntipsychotic Agents
Antipsychotic Agents
 
NEUROTRANSMITTERS 1.pptx
NEUROTRANSMITTERS 1.pptxNEUROTRANSMITTERS 1.pptx
NEUROTRANSMITTERS 1.pptx
 

Mais de kellula

Health Psychology Revision
Health Psychology RevisionHealth Psychology Revision
Health Psychology Revision
kellula
 
Schizophrenia and diagnosis by Angeline David
Schizophrenia and diagnosis by Angeline DavidSchizophrenia and diagnosis by Angeline David
Schizophrenia and diagnosis by Angeline David
kellula
 
Sampling
SamplingSampling
Sampling
kellula
 
Inferential statistics powerpoint
Inferential statistics powerpointInferential statistics powerpoint
Inferential statistics powerpoint
kellula
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
kellula
 
Psychological therapies and schizophrenia
Psychological therapies and schizophreniaPsychological therapies and schizophrenia
Psychological therapies and schizophrenia
kellula
 
Biological explanations by S Laljee
Biological explanations by S LaljeeBiological explanations by S Laljee
Biological explanations by S Laljee
kellula
 

Mais de kellula (10)

Biological Theories of Gender
Biological Theories of GenderBiological Theories of Gender
Biological Theories of Gender
 
Health Psychology Revision
Health Psychology RevisionHealth Psychology Revision
Health Psychology Revision
 
Schizophrenia and diagnosis by Angeline David
Schizophrenia and diagnosis by Angeline DavidSchizophrenia and diagnosis by Angeline David
Schizophrenia and diagnosis by Angeline David
 
Sampling
SamplingSampling
Sampling
 
Inferential statistics powerpoint
Inferential statistics powerpointInferential statistics powerpoint
Inferential statistics powerpoint
 
Freud
FreudFreud
Freud
 
Freud2
Freud2Freud2
Freud2
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Psychological therapies and schizophrenia
Psychological therapies and schizophreniaPsychological therapies and schizophrenia
Psychological therapies and schizophrenia
 
Biological explanations by S Laljee
Biological explanations by S LaljeeBiological explanations by S Laljee
Biological explanations by S Laljee
 

Dopamine hypothesis

  • 2. LEARNING OBJECTIVES You must: • Describe the role of Dopamine (DA) in schizophrenia You should: • Outline evidence to support the hypothesis You could: • Evaluate the Dopamine Hypothesis
  • 3. Lets remind ourselves how neurotransmitters work
  • 4. Lets remind ourselves how neurotransmitters work
  • 5. DOPAMINE HYPOTHESIS The Dopamine hypothesis states that the brain of schizophrenic patients produces more dopamine than normal brains. –Evidence comes from –studies with drugs –post mortems –pet scans
  • 6. Elevated Level of Normal Level of Dopamine In The Brain of a Dopamine In The Schizophrenic Patient Human Brain (specifically the D2 receptor)  Neurons that use the transmitter ‘dopamine’ fire too often and transmit too many messages or too often.  Certain D2 receptors are known to play a key role in guiding attention.  Lowering DA activity helps remove the symptoms of schizophrenia
  • 7. ROLE OF DRUGS –Amphetamines (agonists) lead to increase in DA levels –Large quantities lead to delusions and hallucinations –If drugs are given to schizophrenic patients their symptoms get worse
  • 8. Parkinson’s disease • Parkinson’s sufferers have low levels of dopamine • L-dopa raises DA activity • People with Parkinson's develop schizophrenic symptoms if they take too much L-dopa –Chlorphromazine (given to schizophrenics) reduces the symptoms by blocking D2 receptors
  • 9. POST MORTEM Falkai et al 1988  Autopsies have found that people with schizophrenia have a larger than usual number of dopamine receptors.  Increase of DA in brain structures and receptor density (left amygdala and caudate nucleus putamen) • Concluded that DA production is abnormal for schizophrenia
  • 10. PET SCANS Lindstroem et al (1999) • Radioactively labelled a chemical L-Dopa • administered to 10 patients with schizophrenia and 10 with no diagnosis • L-Dopa taken up quicker with schizophrenic patients • Suggests they were producing more DA than the control group
  • 11. hatch from eggs, but a Which Came First? mother chicken The Chicken or the Egg? must keep an egg warm in order for it to hatch Schizophrenia or Faulty Chemicals? Faulty chemicals cause schizophrenia but schizophrenia may cause faulty chemicals Drugs may influence other systems that impact on schizophrenia so cant be 100% sure about their effects
  • 12. ACTIVITY • Use the evaluation points to write effective AO2 commentary for the studies on the handout • You must comment on how the evidence you use supports or challenges the DA hypothesis. • You should comment on evidence both for and against the hypothesis. • You could use your own skills and knowledge to make additional critical and evaluative points.
  • 13. EVALUATION POINTS • There is a lack of correspondence between taking the drugs and signs of clinical effectiveness. It takes 4 weeks to see any sign that the drugs are working when they begin to block dopamine immediately. We can not seem to explain this time difference. • It could be that the development of receptors in one part of the brain may inhibit the development in another. • Type 1 cases respond well to conventional anti-psychotic drugs. Drugs such as CHLOPROMAZINE: Only effective at relieving the Positive Symptoms of the Illness. • Not good at explaining negative symptoms. Therefore suggested that Type 2 is related to a different kind of abnormality such as brain structure. • PET scans have suggested that drugs did not reduce symptoms of patients diagnosed with disorder for 10 yrs or more • There may be other neurotransmitters involved. • Possible that social and environmental factors trigger the condition.

Notas do Editor

  1. Movie clip: house (ao2 points …… ethics & side effects of biological model approach)